Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges

Management of small cell lung cancer (SCLC) has not changed over the last decades. In more recent years, alterations of DNA repair machinery and other molecular pathways have been identified in SCLC and preclinical data suggest that dysregulation of these pathways might offer new therapeutic opportu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavan, A., Attili, I., Pasello, G., Guarneri, V., Conte, P. F., Bonanno, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683488/
https://www.ncbi.nlm.nih.gov/pubmed/31383005
http://dx.doi.org/10.1186/s40425-019-0690-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683488/
https://www.ncbi.nlm.nih.gov/pubmed/31383005
http://dx.doi.org/10.1186/s40425-019-0690-1

Ejemplares similares